International Response to Andes Virus Hantavirus Cluster on Expedition Cruise

International Coordination Following Hantavirus Cluster on Expedition Cruise

The World Health Organization (WHO) has activated international response protocols following a multi-country cluster of hantavirus infections linked to an expedition cruise ship. The event, which has drawn the attention of global health surveillance networks, centers on the Andes virus, a specific strain most commonly associated with Argentina and Chile and noted for its atypical ability to spread between humans through close contact.[1]

The coordination of this response is being managed under the International Health Regulations (2005), a legally binding framework that commits 196 states parties to report certain disease outbreaks and public health events to WHO. This institutional approach focuses on synchronized information sharing, rapid risk assessment in Geneva and at national level, and aggressive contact tracing to contain the cluster while avoiding disproportionate restrictions on international travel and trade.

Clinical and Epidemiological Profile of the Andes Virus

While most hantaviruses are transmitted strictly from rodents to humans via the inhalation of aerosolized excreta, the Andes virus presents a distinct challenge to public health infrastructure due to its documented, but still limited, human-to-human transmission capability, particularly in close household and healthcare settings.[2] In the Americas, these infections typically manifest as hantavirus cardiopulmonary syndrome, a rapidly progressive respiratory illness with a high case-fatality rate.[3]

Impact and Timeline of the Cruise Ship Event

The incident underscores the vulnerabilities associated with expedition travel, where passengers may be exposed to remote zoonotic reservoirs onshore before returning to high-density, closed environments like cruise ships. Health officials are examining pre- and post-cruise itineraries to distinguish infections acquired during land-based excursions from those that may have resulted from on-board transmission.

• Notification Period: May 2026, following identification of a linked cluster across more than one jurisdiction
• Total Reported Cases: 11 laboratory-confirmed infections under joint investigation
• Total Fatalities: 3 deaths reported to national authorities and WHO
• Primary Site of Infection: Expedition cruise ship and associated excursions to rodent-endemic environments
• Current Status: Ongoing risk assessment, contact tracing and retrospective case finding in countries receiving returning passengers

Authorities are also reviewing ventilation, cabin allocation and on-board medical protocols to understand how a virus that normally relies on rodent exposure may have moved between passengers.

Regulatory Frameworks and National Health Responses

The management of this event requires a high degree of interoperability between WHO and national health agencies because potentially exposed passengers and crew have dispersed to several countries. The involvement of the Spanish Secretary of State for Health and the UK Health Security Agency signals that European governments are treating the cluster as both a clinical and a border-health issue, combining enhanced surveillance with calibrated public messaging to manage perception and prevent panic.

The International Health Regulations serve as the primary mechanism for this collaboration, requiring timely notification of unusual public health events and enabling WHO to coordinate technical guidance, data sharing and travel-related recommendations among affected states. In practice, that means data regarding the 11 cases is analyzed in real time to determine whether the transmission dynamics of the Andes virus on this voyage differ from previous, primarily household-based clusters, and whether additional measures are warranted at ports and airports.

From a systemic perspective, the response is focusing on two primary pillars:

• Surveillance Capacity: Utilizing the Health Emergency Alert and Response Operations (WHE) to monitor for secondary clusters in ports of call, hospitals receiving disembarked passengers, and communities linked to crew movements.
• Behavioral Insights: Applying psychological and communication frameworks to provide clear, practical guidance to travelers and community members-reinforcing that overall risk remains low-without triggering unnecessary cancellations or broader economic disruption to the travel sector.

Systemic Preparedness and Zoonotic Oversight

This cluster highlights a recurring theme in global health governance: the intersection of expanding human exploration, commercial tourism and zoonotic spillover. The ability of a virus to transition from a rodent reservoir to a human host, and in rare circumstances subsequently between humans, necessitates a robust One Health approach that national governments are still in the process of fully operationalizing.

For policymakers, the current event serves as a critical test for the Epidemic and Pandemic Management department (EPM) of WHO and for health ministries overseeing fast-growing cruise and adventure travel markets. Officials are being forced to translate evolving scientific data into concrete decisions on shipboard infection-prevention standards, notification obligations for cruise operators, and guidance for travel insurers and port authorities. The emphasis, WHO advisers say, remains on maintaining clear risk communication, stress-testing cross-border alert systems and strengthening the infrastructure required for rapid detection of rare zoonotic strains in transit-before a localized cluster at sea can become a wider public health emergency on land.